Novartis AG NVS has agreed to acquire privately held U.K. biotechnology company Myricx Bio in a deal valued at up to $1.5 ...

PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class ...

Graduates earn places at world-leading universities across the UK, US, Europe, Australia, Hong Kong and the UAE Results ...

Adds potential first-in-class,N-myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform, designed to address resistance to current payloads Strengthens the Novartis ...

Vietnam's 2026 high school graduation exam produced 11 national toppers and 47 runners-up across the country's five ...

US FDA grants breakthrough therapy designation for INTENT Biologics’ PEP Biologic to treat diabetic foot ulcers: Rochester, Minnesota Friday, July 3, 2026, 09:00 Hrs [IST] INTEN ...

Georgia South Graduate Medical Education celebrated a decade of physician training and welcomed its newest class of residents ...

Permeasis Therapeutics (“Permeasis”), a biotechnology company developing intracellular biologics enabled by its proprietary Membrane Translocation Domain (MTD) platform announced the publication of ...

Nuttida Rungratsameetaweemana is challenging a story neuroscience has told for decades. According to the conventional account, our eyes collect raw information and relay it through a series of nerves ...

INTENT Biologics, a clinical-stage biotechnology company developing first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, announced today that the ...

One receptor can protect antibodies from degradation, extend their half-life and become a drug target itself. Explore the ...

What do Botox, rat poison, weight-loss drugs and a fictional murder investigation have in common? At the University of Nevada ...